Drug Pipeline

Concurrent chemotherapy Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
3
Phase 3
5
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-27 NCT07609121 Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
3
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07328841 Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally… Nasopharyngeal Carcinoma (NPC) Recruiting
NCT06545747 Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic… Non-small Cell Lung Cancer Recruiting
NCT07400536 A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy… Locally Advanced Cervical Carcinoma Recruiting
Phase 2
NCT07439497 Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent… Cervical Cancer Recruiting
NCT01972919 MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic… Unresectable Pancreatic Cancer Active, Not Recruiting
NCT07609121 Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable… NSCLC (Non-small Cell Lung Cancer) Not Yet Recruiting
Sponsors Running Concurrent chemotherapy Trials
Sun Yat-sen University (2) Medical College of Wisconsin (1) Ming-Yuan Chen (1) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) Samsung Medical Center (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Cervical Cancer (2) Pancreatic Cancer (1)
Get alerts when Concurrent chemotherapy trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free